9801 related articles for article (PubMed ID: 12198773)
1. Differential expression of CD44(S) and variant isoforms v3, v10 in three-dimensional cultures of mouse melanoma cell lines.
Shiras A; Bhosale A; Patekar A; Shepal V; Shastry P
Clin Exp Metastasis; 2002; 19(5):445-55. PubMed ID: 12198773
[TBL] [Abstract][Full Text] [Related]
2. Differential expressions of CD44 variants in tumors affecting the central nervous system.
Resnick DK; Resnick NM; Welch WC; Cooper DL
Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
Hashimoto K; Ethridge RT; Evers BM
Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
[TBL] [Abstract][Full Text] [Related]
4. E-cadherin-dependent intercellular adhesion enhances chemoresistance.
Nakamura T; Kato Y; Fuji H; Horiuchi T; Chiba Y; Tanaka K
Int J Mol Med; 2003 Nov; 12(5):693-700. PubMed ID: 14532995
[TBL] [Abstract][Full Text] [Related]
5. Expression of E-, P-, n-cadherins and catenins in human bladder carcinoma cell lines.
Mialhe A; Levacher G; Champelovier P; Martel V; Serres M; Knudsen K; Seigneurin D
J Urol; 2000 Sep; 164(3 Pt 1):826-35. PubMed ID: 10953163
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of cyclin-dependent kinase inhibitors in monolayer and spheroid cultures of tumorigenic and nontumorigenic fibroblasts.
LaRue KE; Bradbury EM; Freyer JP
Cancer Res; 1998 Mar; 58(6):1305-14. PubMed ID: 9515820
[TBL] [Abstract][Full Text] [Related]
7. Ras farnesylation inhibitor FTI-277 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis.
Nam JS; Ino Y; Sakamoto M; Hirohashi S
Jpn J Cancer Res; 2002 Sep; 93(9):1020-8. PubMed ID: 12359056
[TBL] [Abstract][Full Text] [Related]
8. Cell-to-cell contact influences proliferative marker expression and apoptosis in MIN6 cells grown in islet-like structures.
Luther MJ; Davies E; Muller D; Harrison M; Bone AJ; Persaud SJ; Jones PM
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E502-9. PubMed ID: 15479950
[TBL] [Abstract][Full Text] [Related]
9. Plasticity of cadherin-catenin expression in the melanocyte lineage.
Jouneau A; Yu YQ; Pasdar M; Larue L
Pigment Cell Res; 2000 Aug; 13(4):260-72. PubMed ID: 10952394
[TBL] [Abstract][Full Text] [Related]
10. An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma.
Tomlinson JS; Alpaugh ML; Barsky SH
Cancer Res; 2001 Jul; 61(13):5231-41. PubMed ID: 11431364
[TBL] [Abstract][Full Text] [Related]
11. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
[TBL] [Abstract][Full Text] [Related]
12. Abnormal expression and function of the E-cadherin-catenin complex in gastric carcinoma cell lines.
Jawhari AU; Noda M; Farthing MJ; Pignatelli M
Br J Cancer; 1999 May; 80(3-4):322-30. PubMed ID: 10408833
[TBL] [Abstract][Full Text] [Related]
13. E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1).
St Croix B; Sheehan C; Rak JW; Flørenes VA; Slingerland JM; Kerbel RS
J Cell Biol; 1998 Jul; 142(2):557-71. PubMed ID: 9679152
[TBL] [Abstract][Full Text] [Related]
14. Requirement of protein kinase Calpha, extracellular matrix remodeling, and cell-matrix interaction for transforming growth factorbeta-regulated expression of E-cadherin and catenins.
Wang H; Chakrabarty S
J Cell Physiol; 2001 May; 187(2):188-95. PubMed ID: 11267998
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of spheroid cells from human malignant melanoma cell line WM-266-4.
Na YR; Seok SH; Kim DJ; Han JH; Kim TH; Jung H; Lee BH; Park JH
Tumour Biol; 2009; 30(5-6):300-9. PubMed ID: 19940551
[TBL] [Abstract][Full Text] [Related]
16. M-cadherin-mediated cell adhesion and complex formation with the catenins in myogenic mouse cells.
Kuch C; Winnekendonk D; Butz S; Unvericht U; Kemler R; Starzinski-Powitz A
Exp Cell Res; 1997 May; 232(2):331-8. PubMed ID: 9168809
[TBL] [Abstract][Full Text] [Related]
17. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.
Conacci-Sorrell ME; Ben-Yedidia T; Shtutman M; Feinstein E; Einat P; Ben-Ze'ev A
Genes Dev; 2002 Aug; 16(16):2058-72. PubMed ID: 12183361
[TBL] [Abstract][Full Text] [Related]
18. Modulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by cell cycle inhibitors.
Wartenberg M; Fischer K; Hescheler J; Sauer H
Biochim Biophys Acta; 2002 Feb; 1589(1):49-62. PubMed ID: 11909640
[TBL] [Abstract][Full Text] [Related]
19. Possible contribution of CD44 variant 6 and nuclear beta-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma.
Masaki T; Goto A; Sugiyama M; Matsuoka H; Abe N; Sakamoto A; Atomi Y
Cancer; 2001 Nov; 92(10):2539-46. PubMed ID: 11745187
[TBL] [Abstract][Full Text] [Related]
20. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G
Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
